Robert Burns Analyst PerformanceAnalyst at BTIG ResearchRobert Burns is a stock analyst at BTIG Research focused in the medical sector, covering 51 publicly traded companies. Over the past year, Robert Burns has issued 142 stock ratings, including strong buy, buy, hold, and sell recommendations. While full access to Robert Burns' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Robert Burns' coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings303 Last 6 YearsBuy Recommendations91.06% 275 Buy RatingsCompanies Covered51 Unique Companies Ratings Distribution302RatingsDistribution of strong buy, buy, hold, and sell ratings by Robert Burns.RatingPercentageCount Strong Buy0.3%1 ratings Buy90.7%274 ratings Hold8.6%26 ratings Sell0.3%1 ratingsOut of 302 total stock ratings issued by Robert Burns at BTIG Research, the majority (90.7%) have been Buy recommendations, followed by 8.6% Hold, 0.3% Strong Buy, and 0.3% Sell.Best & Worst CallsBest Call000000.0%TNGXApr 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%FATEJan 2022Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ94.1% of companies on NASDAQ48 companiesNYSE3.9% of companies on NYSE2 companiesNYSEAMERICAN2.0% of companies on NYSEAMERICAN1 companyRobert Burns, an analyst at BTIG Research, currently covers 51 companies listed on NASDAQ, NYSE and NYSEAMERICAN, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical48 companies94.1%Manufacturing2 companies3.9%Financial Services1 company2.0%Robert Burns of BTIG Research specializes in stock coverage within the Medical sector, with additional focus on Manufacturing and Financial Services companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE38 companies74.5%MED - DRUGS5 companies9.8%PHARMACEUTICAL PREPARATIONS4 companies7.8%Miscellaneous1 company2.0%SURGICAL & MEDICAL INSTRUMENTS1 company2.0%INVESTMENT OFFICES1 company2.0%MED PRODUCTS1 company2.0% Robert Burns' Ratings History at BTIG Research Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsELTXElicio Therapeutics6/15/2026Boost Price Target$14.85$23.00Buy$0.0000.00% ROINRIXNurix Therapeutics6/10/2026Reiterated Rating$15.64$32.00Buy$0.0000.00% ROITNGXTango Therapeutics6/9/2026Boost Price Target$31.12$66.00Buy$0.0000.00% ROIADCTADC Therapeutics6/8/2026Downgrade$1.03Neutral$0.0000.00% ROIORICOric Pharmaceuticals6/8/2026Reiterated Rating$7.50$25.00Buy$0.0000.00% ROIFATEFate Therapeutics6/8/2026Reiterated Rating$1.98$7.00Buy$0.0000.00% ROICGEMCullinan Therapeutics6/8/2026Reiterated Rating$13.51$30.00Buy$0.0000.00% ROIRADXRadiopharm Theranostics6/4/2026Initiated Coverage$4.49$6.00Buy$0.0000.00% ROIZYMEZymeworks6/3/2026Reiterated Rating$24.11$46.00Buy$0.0000.00% ROIAKTSAktis Oncology6/2/2026Boost Price Target$19.81$35.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. RVMDRevolution Medicines6/1/2026Boost Price Target$163.40$195.00Buy$0.0000.00% ROICRDFCardiff Oncology6/1/2026Downgrade$1.90Neutral$0.0000.00% ROIELTXElicio Therapeutics5/28/2026Reiterated Rating$10.77$17.00Buy$0.0000.00% ROIBOLTBolt Biotherapeutics5/28/2026Reiterated Rating$5.28$7.00Buy$0.0000.00% ROIRLAYRelay Therapeutics5/26/2026Boost Price Target$13.53$28.00Buy$0.0000.00% ROIIMMXImmix Biopharma5/22/2026Boost Price Target$8.90$20.00Buy$0.0000.00% ROICRBUCaribou Biosciences5/11/2026Boost Price Target$1.94$11.00Buy$0.0000.00% ROIEXELExelixis5/7/2026Boost Price Target$48.70$56.00Buy$0.0000.00% ROICOGTCogent Biosciences5/6/2026Boost Price Target$36.97$55.00Buy$0.0000.00% ROIKPTIKaryopharm Therapeutics5/6/2026Boost Price Target$9.41$13.00Buy$0.0000.00% ROIADCTADC Therapeutics5/5/2026Reiterated Rating$3.64$8.00Buy$0.0000.00% ROINUVBNuvation Bio5/5/2026Reiterated Rating$4.45$17.00Buy$0.0000.00% ROIFATEFate Therapeutics5/4/2026Boost Price Target$1.53$7.00Buy$0.0000.00% ROIRLAYRelay Therapeutics4/29/2026Boost Price Target$13.03$25.00Buy$0.0000.00% ROIBDTXBlack Diamond Therapeutics4/29/2026Boost Price Target$2.70$11.00Buy$0.0000.00% ROICGEMCullinan Therapeutics4/28/2026Boost Price Target$12.85$30.00Buy$0.0000.00% ROIPRLDPrelude Therapeutics4/27/2026Boost Price Target$4.70$8.00Buy$0.0000.00% ROINRIXNurix Therapeutics4/27/2026Reiterated Rating$16.68$32.00Buy$0.0000.00% ROIBNTXBioNTech4/27/2026Reiterated Rating$105.46$130.00Buy$0.0000.00% ROIRVMDRevolution Medicines4/22/2026Reiterated Rating$148.90Buy$0.0000.00% ROIMOLNMolecular Partners4/22/2026Reiterated Rating$4.49$13.00Buy$0.0000.00% ROIALLOAllogene Therapeutics4/14/2026Boost Price Target$3.04$12.00Buy$0.0000.00% ROITLXTelix Pharmaceuticals4/13/2026Reiterated Rating$10.54$20.00Buy$0.0000.00% ROIREPLReplimune Group4/13/2026Reiterated Rating$4.77Sell$0.0000.00% ROINRIXNurix Therapeutics4/10/2026Reiterated Rating$16.24$32.00Buy$0.0000.00% ROICRBUCaribou Biosciences4/7/2026Reiterated Rating$1.95$9.00Buy$0.0000.00% ROITLXTelix Pharmaceuticals4/7/2026Reiterated Rating$9.09$20.00Buy$0.0000.00% ROIORICOric Pharmaceuticals4/2/2026Reiterated Rating$7.47$25.00Buy$0.0000.00% ROIBNTXBioNTech3/31/2026Lower Price Target$85.25$130.00Buy$0.0000.00% ROIAKTSAktis Oncology3/31/2026Boost Price Target$16.54$33.00Buy$0.0000.00% ROISpaceX is offering you shares. Don't take them. (Ad)SpaceX is reserving 30% of its IPO shares for retail investors through Robinhood, Fidelity, and Schwab. At a $1.75 trillion valuation and 266 times earnings, you're buying in at the most expensive IPO in history - right when institutions who got in at $800 billion need someone to sell to. Dylan Jovine has identified a small company in Musk's supply chain that builds the power infrastructure Colossus can't run without - and it's still trading at a fraction of its value.Skip the IPO trap and get the backdoor ticker for freeBCAXBicara Therapeutics3/31/2026Boost Price Target$19.04$42.00Buy$0.0000.00% ROIIMMXImmix Biopharma3/27/2026Boost Price Target$8.72$15.00Buy$0.0000.00% ROIELVNEnliven Therapeutics3/26/2026Boost Price Target$35.53$56.00Buy$0.0000.00% ROIKPTIKaryopharm Therapeutics3/25/2026Lower Price Target$5.44$8.00Buy$0.0000.00% ROINRIXNurix Therapeutics3/24/2026Reiterated Rating$14.69$32.00Buy$0.0000.00% ROIACETAdicet Bio3/23/2026Lower Price Target$6.92$27.00Buy$0.0000.00% ROIRLAYRelay Therapeutics3/23/2026Boost Price Target$9.91$19.00Buy$0.0000.00% ROIADCTADC Therapeutics3/23/2026Boost Price Target$3.88$8.00Buy$0.0000.00% ROICATXPerspective Therapeutics3/23/2026Boost Price Target$4.45$13.00Buy$0.0000.00% ROIOKUROnKure Therapeutics3/16/2026Lower Price Target$3.78$27.00Buy$0.0000.00% ROIMOLNMolecular Partners3/16/2026Reiterated Rating$4.22$13.00Buy$0.0000.00% ROIELTXElicio Therapeutics3/13/2026Boost Price Target$10.90$17.00Buy$0.0000.00% ROIORICOric Pharmaceuticals3/13/2026Reiterated Rating$11.76$25.00Buy$0.0000.00% ROIBOLTBolt Biotherapeutics3/13/2026Reiterated Rating$4.05$7.00Buy$0.0000.00% ROIAKTSAktis Oncology3/9/2026Initiated Coverage$18.81$30.00Buy$0.0000.00% ROIAVBPArriVent BioPharma3/6/2026Boost Price Target$25.25$44.00Buy$0.0000.00% ROIBBOTBridgeBio Oncology Therapeutics3/6/2026Boost Price Target$9.89$29.00Buy$0.0000.00% ROITNGXTango Therapeutics3/6/2026Boost Price Target$16.80$27.00Buy$0.0000.00% ROIZYMEZymeworks3/6/2026Boost Price Target$24.80$46.00Buy$0.0000.00% ROIORICOric Pharmaceuticals2/24/2026Boost Price Target$12.46$25.00Buy$0.0000.00% ROIKPTIKaryopharm Therapeutics2/18/2026Reiterated Rating$9.40$15.00Buy$0.0000.00% ROIEXELExelixis2/12/2026Boost Price Target$42.94$54.00Buy$0.0000.00% ROIEXELExelixis2/3/2026Reiterated Rating$42.81$52.00Buy$0.0000.00% ROIHURATuHURA Biosciences2/3/2026Reiterated Rating$0.52$10.00Buy$0.0000.00% ROICATXPerspective Therapeutics1/30/2026Boost Price Target$4.26$12.00Buy$0.0000.00% ROINRIXNurix Therapeutics1/29/2026Boost Price Target$17.87$32.00Buy$0.0000.00% ROICRDFCardiff Oncology1/28/2026Reiterated Rating$2.00$10.00Buy$0.0000.00% ROIMOLNMolecular Partners1/27/2026Initiated Coverage$4.09$13.00Buy$0.0000.00% ROIEXELExelixis1/27/2026Boost Price Target$43.61$52.00Buy$0.0000.00% ROIMOLNMolecular Partners1/27/2026Initiated Coverage$4.00$13.00Buy$0.0000.00% ROIACETAdicet Bio1/21/2026Reiterated Rating$7.90$50.00Buy$0.0000.00% ROITLXTelix Pharmaceuticals1/21/2026Reiterated Rating$7.73$20.00Buy$0.0000.00% ROIBCAXBicara Therapeutics1/14/2026Reiterated Rating$17.53Buy$0.0000.00% ROINUVBNuvation Bio1/12/2026Lower Price Target$8.03$17.00Buy$0.0000.00% ROIHURATuHURA Biosciences1/9/2026Reiterated Rating$0.75$10.00Buy$0.0000.00% ROICGEMCullinan Therapeutics1/8/2026Boost Price Target$10.71$27.00Buy$0.0000.00% ROIEXELExelixis1/8/2026Boost Price Target$44.79$52.00Buy$0.0000.00% ROICOGTCogent Biosciences1/6/2026Boost Price Target$34.26$52.00Buy$0.0000.00% ROITLXTelix Pharmaceuticals12/22/2025Reiterated Rating$7.80$20.00Buy$0.0000.00% ROIBNTXBioNTech12/11/2025Reiterated Rating$96.00$140.00Buy$0.0000.00% ROINUVBNuvation Bio12/11/2025Boost Price Target$7.90$18.00Buy$0.0000.00% ROINRIXNurix Therapeutics12/10/2025Boost Price Target$19.55$31.00Buy$0.0000.00% ROINUVBNuvation Bio12/1/2025Reiterated Rating$8.05$10.00Buy$0.0000.00% ROICGEMCullinan Therapeutics11/20/2025Boost Price Target$9.10$26.00Buy$0.0000.00% ROIZYMEZymeworks11/18/2025Boost Price Target$23.90$32.00Buy$0.0000.00% ROIORICOric Pharmaceuticals11/14/2025Boost Price Target$13.08$23.00Buy$0.0000.00% ROICOGTCogent Biosciences11/13/2025Boost Price Target$35.26$50.00Buy$0.0000.00% ROIBNTXBioNTech11/10/2025Boost Price Target$103.14$140.00Buy$0.0000.00% ROIACETAdicet Bio11/7/2025Boost Price Target$10.83$144.00Buy$0.0000.00% ROIRVMDRevolution Medicines11/6/2025Boost Price Target$59.34$73.00Buy$0.0000.00% ROIHow to play the Biggest IPO in stock market history! (Ad)SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insiders and institutional holders have been sitting on positions for years and will exit the moment shares hit the market. Lance Ippolito has identified five stocks directly positioned to benefit from the SpaceX launch and the space investing wave it triggers, without the brutal IPO volatility. These picks carry none of the hype risk and all of the tailwind.Get all five tickers now, completely freeCRBUCaribou Biosciences11/5/2025Boost Price Target$2.17$9.00Buy$0.0000.00% ROIEXELExelixis11/5/2025Boost Price Target$39.06$49.00Buy$0.0000.00% ROICOGTCogent Biosciences11/4/2025Reiterated Rating$15.50$21.00Buy$0.0000.00% ROIMGNXMacroGenics11/3/2025Reiterated Rating$1.66$2.00Neutral$0.0000.00% ROIFATEFate Therapeutics10/31/2025Upgrade$1.29$5.00Buy$0.0000.00% ROIZYMEZymeworks10/27/2025Reiterated Rating$17.87Buy$0.0000.00% ROINRIXNurix Therapeutics10/27/2025Lower Price Target$11.98$28.00Buy$0.0000.00% ROIREPLReplimune Group10/27/2025Upgrade$8.80$12.00Buy$0.0000.00% ROIRPTXRepare Therapeutics10/27/2025Lower Price Target$1.90$3.00Buy$0.0000.00% ROIBOLTBolt Biotherapeutics10/20/2025Set Price Target$5.74$7.00Buy$0.0000.00% ROINRIXNurix Therapeutics10/20/2025Reiterated Rating$9.84$33.00Buy$0.0000.00% ROIBOLTBolt Biotherapeutics10/20/2025Initiated Coverage$5.86$7.00Buy$0.0000.00% ROIADCTADC Therapeutics10/16/2025Lower Price Target$4.24$7.00Buy$0.0000.00% ROINRIXNurix Therapeutics10/14/2025Lower Price Target$9.72$33.00Buy$0.0000.00% ROIZYMEZymeworks10/14/2025Set Price Target$18.11$26.00Buy$0.0000.00% ROIKPTIKaryopharm Therapeutics10/13/2025Upgrade$5.50$15.00Buy$0.0000.00% ROICATXPerspective Therapeutics10/3/2025Reiterated Rating$3.49$10.00Buy$0.0000.00% ROIPRLDPrelude Therapeutics9/23/2025Reiterated Rating$1.01$5.00Buy$0.0000.00% ROINUVBNuvation Bio9/19/2025Reiterated Rating$3.16$10.00Buy$0.0000.00% ROICATXPerspective Therapeutics9/19/2025Reiterated Rating$3.29$10.00Buy$0.0000.00% ROICGEMCullinan Therapeutics9/12/2025Reiterated Rating$6.62$24.00Buy$0.0000.00% ROIIMMXImmix Biopharma9/12/2025Boost Price Target$2.22$8.00Buy$0.0000.00% ROITLXTelix Pharmaceuticals9/10/2025Lower Price Target$9.66$20.00Buy$0.0000.00% ROIBNTXBioNTech9/8/2025Reiterated Rating$112.46$136.00Buy$0.0000.00% ROIREPLReplimune Group9/8/2025Reiterated Rating$6.33Neutral$0.0000.00% ROIRLAYRelay Therapeutics8/26/2025Lower Price Target$3.51$14.00Buy$0.0000.00% ROIOKUROnKure Therapeutics8/26/2025Reiterated Rating$2.75$34.00Buy$0.0000.00% ROIBCAXBicara Therapeutics8/22/2025Lower Price Target$11.63$40.00Buy$0.0000.00% ROICGEMCullinan Therapeutics8/21/2025Initiated Coverage$7.47$24.00Buy$0.0000.00% ROIORICOric Pharmaceuticals8/14/2025Lower Price Target$9.83$19.00Buy$0.0000.00% ROIBNTXBioNTech8/14/2025Lower Price Target$111.87$136.00Buy$0.0000.00% ROIAVBPArriVent BioPharma8/12/2025Reiterated Rating$17.42$42.00Buy$0.0000.00% ROIEXELExelixis8/12/2025Lower Price Target$37.41$46.00Buy$0.0000.00% ROIBDTXBlack Diamond Therapeutics8/11/2025Lower Price Target$2.40$10.00Buy$0.0000.00% ROIYMABY-mAbs Therapeutics8/6/2025Reiterated Rating$8.52$8.60Neutral$0.0000.00% ROICOGTCogent Biosciences8/6/2025Lower Price Target$11.36$21.00Buy$0.0000.00% ROICRDFCardiff Oncology8/6/2025Lower Price Target$2.57$10.00Buy$0.0000.00% ROIREPLReplimune Group7/23/2025Downgrade$2.81Neutral$0.0000.00% ROIACETAdicet Bio7/23/2025Upgrade$12.03$64.00Strong-Buy$0.0000.00% ROIAVBPArriVent BioPharma7/22/2025Reiterated Rating$21.55$40.00Buy$0.0000.00% ROIELTXElicio Therapeutics7/17/2025Boost Price Target$9.05$13.00Buy$0.0000.00% ROIKPTIKaryopharm Therapeutics7/16/2025Downgrade$4.24Neutral$0.0000.00% ROINRIXNurix Therapeutics7/14/2025Lower Price Target$12.42$34.00Buy$0.0000.00% ROIKPTIKaryopharm Therapeutics7/11/2025Initiated Coverage$5.00$27.00Buy$0.0000.00% ROICOGTCogent Biosciences7/8/2025Boost Price Target$9.33$22.00Buy$0.0000.00% ROITLXTelix Pharmaceuticals7/3/2025Initiated Coverage$16.50$23.00Buy$0.0000.00% ROIZYMEZymeworks7/3/2025Reiterated Rating$12.89$13.00Neutral$0.0000.00% ROIREPLReplimune Group7/3/2025Reiterated Rating$9.55$22.00Buy$0.0000.00% ROIELVNEnliven Therapeutics7/2/2025Boost Price Target$19.65$48.00Buy$0.0000.00% ROIEXELExelixis6/30/2025Boost Price Target$43.67$53.00Buy$0.0000.00% ROITesla's robot factory goes live this summer (Ad)On Tesla's Q1 2026 earnings call, Elon Musk confirmed Optimus robot production at the Fremont factory begins late July or August - with a target of one million units per year. One trader using a proprietary institutional capital flow system has identified five small companies he believes are directly in Tesla's Optimus supply chain. Two are trading under $4.See all five supply chain picks before the production window opensBNTXBioNTech6/25/2025Reiterated Rating$105.09$138.00Buy$0.0000.00% ROIBNTXBioNTech6/16/2025Lower Price Target$106.57$138.00Buy$00.0000.00% ROIEXELExelixis6/12/2025Reiterated Rating$41.43$47.00Buy$00.0000.00% ROIBNTXBioNTech6/5/2025Boost Price Target$111.21$145.00Buy$00.0000.00% ROIIMMXImmix Biopharma6/4/2025Reiterated Rating$2.11$7.00Buy$0.0000.00% ROIBNTXBioNTech5/22/2025Reiterated Rating$99.09$134.00Buy$00.0000.00% ROICOGTCogent Biosciences5/20/2025Lower Price Target$5.03$12.00Buy$00.0000.00% ROIYMABY-mAbs Therapeutics5/19/2025Lower Price Target$4.10$11.00Buy$0.0000.00% ROIELVNEnliven Therapeutics5/15/2025Boost Price Target$19.89$40.00Buy$00.0000.00% ROIRVMDRevolution Medicines5/14/2025Reiterated Rating$40.01$72.00Buy$000.0000.00% ROIBNTXBioNTech5/14/2025Reiterated Rating$93.89$134.00Buy$00.0000.00% ROIAVBPArriVent BioPharma5/14/2025Boost Price Target$18.76$40.00Buy$00.0000.00% ROICRDFCardiff Oncology5/9/2025Boost Price Target$2.63$18.00Buy$0.0000.00% ROIORICOric Pharmaceuticals5/5/2025Reiterated Rating$5.67$21.00Buy$0.0000.00% ROIPRLDPrelude Therapeutics5/5/2025Reiterated Rating$0.89$5.00Buy$0.0000.00% ROISWTXSpringWorks Therapeutics4/30/2025Reiterated Rating$46.24$47.00Neutral$0.0000.00% ROICRBUCaribou Biosciences4/28/2025Reiterated Rating$0.77$3.00Buy$0.0000.00% ROITNGXTango Therapeutics4/14/2025Reiterated Rating$1.41$13.00Buy$00.0000.00% ROIPRLDPrelude Therapeutics4/8/2025Reiterated Rating$0.65$5.00Buy$0.0000.00% ROIELTXElicio Therapeutics4/2/2025Reiterated Rating$4.95$10.00Buy$00.0000.00% ROINRIXNurix Therapeutics4/2/2025Reiterated Rating$10.47$36.00Buy$00.0000.00% ROIBNTXBioNTech4/1/2025Lower Price Target$91.06$145.00Buy$00.0000.00% ROIADCTADC Therapeutics3/31/2025Reiterated Rating$1.49$8.00Buy$0.0000.00% ROIEXELExelixis3/27/2025Reiterated Rating$37.01$40.00Buy$00.0000.00% ROIMGNXMacroGenics3/25/2025Lower Price Target$1.96$2.00Neutral$0.0000.00% ROIELVNEnliven Therapeutics3/21/2025Boost Price Target$20.92$39.00Buy$00.0000.00% ROIYMABY-mAbs Therapeutics3/21/2025Lower Price Target$4.92$12.00Buy$0.0000.00% ROIPMVPPMV Pharmaceuticals3/20/2025Reiterated Rating$1.28$5.00Buy$0.0000.00% ROIALLOAllogene Therapeutics3/19/2025Lower Price Target$1.69$8.00Buy$0.0000.00% ROICRBUCaribou Biosciences3/19/2025Reiterated Rating$0.95$9.00Buy$0.0000.00% ROIBDTXBlack Diamond Therapeutics3/18/2025Boost Price Target$1.71$12.00Buy$0.0000.00% ROICATXPerspective Therapeutics3/13/2025Initiated Coverage$2.66$10.00Buy$0.0000.00% ROINUVBNuvation Bio3/10/2025Lower Price Target$2.03$10.00Buy$0.0000.00% ROIZYMEZymeworks3/10/2025Boost Price Target$11.09$13.00Neutral$00.0000.00% ROIRPTXRepare Therapeutics3/7/2025Lower Price Target$1.19$5.00Buy$0.0000.00% ROIRLAYRelay Therapeutics3/7/2025Reiterated Rating$3.48$16.00Buy$0.0000.00% ROIAVBPArriVent BioPharma3/7/2025Reiterated Rating$21.81$39.00Buy$00.0000.00% ROIHURATuHURA Biosciences3/3/2025Initiated Coverage$2.41$13.00Buy$0.0000.00% ROIRVMDRevolution Medicines3/3/2025Boost Price Target$40.74$73.00Buy$000.0000.00% ROICRDFCardiff Oncology2/28/2025Boost Price Target$4.06$17.00Buy$0.0000.00% ROISWTXSpringWorks Therapeutics2/21/2025Reiterated Rating$58.64$74.00Buy$0.0000.00% ROIORICOric Pharmaceuticals2/21/2025Reiterated Rating$7.63$21.00Buy$00.0000.00% ROIEXELExelixis2/13/2025Reiterated Rating$32.80$40.00Buy$00.0000.00% ROIREPLReplimune Group2/13/2025Boost Price Target$13.79$22.00Buy$0.0000.00% ROISWTXSpringWorks Therapeutics2/12/2025Reiterated Rating$55.13$74.00Buy$0.0000.00% ROIORICOric Pharmaceuticals2/11/2025Reiterated Rating$11.23$21.00Buy$00.0000.00% ROIIMMXImmix Biopharma2/10/2025Reiterated Rating$2.01$7.00Buy$0.0000.00% ROICRGXCARGO Therapeutics1/30/2025Downgrade$13.19Neutral$0.0000.00% ROINRIXNurix Therapeutics1/29/2025Boost Price Target$19.56$36.00Buy$00.0000.00% ROIATRAAtara Biotherapeutics1/28/2025Reiterated Rating$7.37Neutral$0.0000.00% ROIStranded On The Flood Plains of History (Ad)The petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed U.S. Treasury holdings by 45% from peak, and central banks are swapping dollars for gold at the fastest pace since the Cold War. Porter Stansberry believes Trump is channeling more than $3 trillion toward securing the minerals, chips, and infrastructure that make AI possible - and companies at those chokepoints like Vertiv (up 500%), GE Vernova (up 700%), and Arista Networks (up 750%) are already moving. Porter's new briefing names one asset to buy today plus five stocks positioned at the narrowest chokepoints of what he calls the Silicon Dollar.Read Porter's full briefing and get the ticker names todayEXELExelixis1/27/2025Reiterated Rating$32.38$40.00Buy$00.0000.00% ROINUVBNuvation Bio1/23/2025Boost Price Target$2.65$11.00Buy$0.0000.00% ROIATRAAtara Biotherapeutics1/22/2025Reiterated Rating$6.05Neutral$0.0000.00% ROIAVBPArriVent BioPharma1/22/2025Boost Price Target$25.31$39.00Buy$00.0000.00% ROIREPLReplimune Group1/22/2025Boost Price Target$11.85$21.00Buy$0.0000.00% ROICOGTCogent Biosciences1/14/2025Lower Price Target$7.57$14.00Buy$00.0000.00% ROIRLAYRelay Therapeutics1/14/2025Reiterated Rating$4.78$16.00Buy$0.0000.00% ROIYMABY-mAbs Therapeutics1/13/2025Reiterated Rating$6.89$22.00Buy$0.0000.00% ROIORICOric Pharmaceuticals1/13/2025Reiterated Rating$8.29$21.00Buy$0.0000.00% ROIEXELExelixis1/10/2025Boost Price Target$34.50$40.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James FinancialDeutsche Bank Aktiengesellschaft Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.